BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 15004489)

  • 1. Serum insulin-like growth factor-II and alpha-fetoprotein as tumor markers of hepatocellular carcinoma.
    Tsai JF; Jeng JE; Chuang LY; You HL; Ho MS; Lai CS; Wang LY; Hsieh MY; Chen SC; Chuang WL; Lin ZY; Yu ML; Dai CY
    Tumour Biol; 2003; 24(6):291-8. PubMed ID: 15004489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum insulin-like growth factor-II as a serologic marker of small hepatocellular carcinoma.
    Tsai JF; Jeng JE; Chuang LY; You HL; Wang LY; Hsieh MY; Chen SC; Chuang WL; Lin ZY; Yu ML; Dai CY
    Scand J Gastroenterol; 2005 Jan; 40(1):68-75. PubMed ID: 15841717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary transforming growth factor α and serum α-fetoprotein as tumor markers of hepatocellular carcinoma.
    Jeng JE; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
    Tumour Biol; 2014 Apr; 35(4):3689-98. PubMed ID: 24375326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-II is a useful marker to detect hepatocellular carcinoma?
    Morace C; Cucunato M; Bellerone R; De Caro G; Crinò S; Fortiguerra A; Spadaro F; Zirilli A; Alibrandi A; Consolo P; Luigiano C; Resta ML; Ferraù O; Spadaro A
    Eur J Intern Med; 2012 Sep; 23(6):e157-61. PubMed ID: 22863442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of urinary transforming growth factor-beta1 and serum alpha-fetoprotein as tumour markers of hepatocellular carcinoma.
    Tsai JF; Jeng JE; Chuang LY; Yang ML; Ho MS; Chang WY; Hsieh MY; Lin ZY; Tsai JH
    Br J Cancer; 1997; 75(10):1460-6. PubMed ID: 9166938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma.
    Tsai JF; Jeng JE; Ho MS; Chang WY; Lin ZY; Tsai JH
    Br J Cancer; 1995 Aug; 72(2):442-6. PubMed ID: 7543774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
    Lim TS; Kim DY; Han KH; Kim HS; Shin SH; Jung KS; Kim BK; Kim SU; Park JY; Ahn SH
    Scand J Gastroenterol; 2016 Mar; 51(3):344-53. PubMed ID: 26340708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
    Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
    PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development].
    Kim KA; Lee JS; Jung ES; Kim JY; Bae WK; Kim NH; Moon YS
    Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma.
    Seo SI; Kim HS; Kim WJ; Shin WG; Kim DJ; Kim KH; Jang MK; Lee JH; Kim JS; Kim HY; Kim DJ; Lee MS; Park CK
    World J Gastroenterol; 2015 Apr; 21(13):3928-35. PubMed ID: 25852278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot study of elevated levels of insulin-like growth factor-binding protein-2 as indicators of hepatocellular carcinoma.
    Ranke MB; Maier KP; Schweizer R; Stadler B; Schleicher S; Elmlinger MW; Flehmig B
    Horm Res; 2003; 60(4):174-80. PubMed ID: 14530605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of alpha-1-fetoprotein (AFP) as a biomarker for hepatocellular carcinoma recurrence after liver transplantation.
    Nörthen A; Asendorf T; Walson PD; Oellerich M
    Clin Biochem; 2018 Feb; 52():20-25. PubMed ID: 29054441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary transforming growth factor-beta 1 in relation to serum alpha-fetoprotein in hepatocellular carcinoma.
    Tsai JF; Jeng JE; Chuang LY; Chang WY; Hsieh MY; Lin ZY; Tsai JH
    Scand J Gastroenterol; 1997 Mar; 32(3):254-60. PubMed ID: 9085463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis.
    Wang Y; Yang H; Xu H; Lu X; Sang X; Zhong S; Huang J; Mao Y
    J Gastroenterol Hepatol; 2014 Mar; 29(3):597-602. PubMed ID: 24236824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
    Chang TS; Wu YC; Tung SY; Wei KL; Hsieh YY; Huang HC; Chen WM; Shen CH; Lu CH; Wu CS; Tsai YH; Huang YH
    Am J Gastroenterol; 2015 Jun; 110(6):836-44; quiz 845. PubMed ID: 25869392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.
    Zekri AR; Youssef AS; Bakr YM; Gabr RM; Ahmed OS; Elberry MH; Mayla AM; Abouelhoda M; Bahnassy AA
    World J Gastroenterol; 2016 Apr; 22(16):4168-82. PubMed ID: 27122667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of Alpha Fetoprotein in Combination with Alpha-1-acid Glycoprotein for Diagnosis of Hepatocellular Carcinoma Among Liver Cirrhosis Patients.
    Gani RA; Suryamin M; Hasan I; Lesmana CR; Sanityoso A
    Acta Med Indones; 2015 Jul; 47(3):216-22. PubMed ID: 26586387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.
    Cui R; Wang B; Ding H; Shen H; Li Y; Chen X
    Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of α-fetoprotein as a diagnostic tool for hepatocellular carcinoma in Korea.
    Ahn DG; Kim HJ; Kang H; Lee HW; Bae SH; Lee JH; Paik YH; Lee JS
    Korean J Intern Med; 2016 Jan; 31(1):46-53. PubMed ID: 26767857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.